Pfizer 2-dose vaccine 95 per cent effective, no serious side effects

Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their two-dose coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus.

The company said that no serious side effects...